The Massey Cancer Center is a matrix center located at Virginia Commonwealth University. The mission of the Cancer Center is to provide comprehensive, cancer-focused basic, clinical, and population research, clinical services, outreach, and education to the State of Virginia and the nation. The major goals of the Cancer Center are 1) to facilitate high-quality basic, clinical, and population-based research focused on the cancer problem and 2) to promote interdisciplinary collaborations among the scientific programs and members of the Cancer Center in order to generate more effective interventions for cancer prevention and treatment. During the last project period, NCI funding for Cancer Center members increased from $9,352,802 (annual, total) to $15,777,576, and total peer-reviewed funding from $24,570,886 to $33,125,861. During this period we expanded our basic science research base, increased cancer focus in every research program, and increased clinical research activity. The Cancer Center's clinical facilities were renovated, and a new 80,000 g.s.ft. Cancer Center research laboratory building was completed. Major goals for the next grant period are to substantially broaden our clinical research activities, further increase the depth and scope of our basic research, and increase the focus in each of our research programs on the problems of health care disparities among racial, ethnic, and other underserved populations. Research activities of the Massey Cancer Center are carried out through five established research programs: Molecular Cancer Therapeutics, Cancer Cell Biology, Immune Mechanisms, Cancer Prevention and Control, and Radiation Biology and Oncology. The programs are structured to include both basic research and either clinical/translational or applied population research so as to facilitate transdisciplinary collaboration and rapid implementation of research findings in the treatment and prevention of cancer. In order to provide support for the predominantly peer-reviewed research base of the Massey Cancer Center programs, the Cancer Center supports several shared resources: Clinical Research; Biostatistics; Flow Cytometry; Molecular Biology; Nucleic Acid sequencing and synthesis; Structural Biology; Transgenic/Knockout Mouse; Cancer Research Informatics and Services; Tissue and Data Acquisition and Analysis; and Virus Vector production. This application requests continuation of the Cancer Center Support Grant to provide partial support for these shared resources as well as for senior leadership, program leadership, administration, protocol-specific research, program planning and evaluation, protocol review and monitoring, data and safety monitoring, and developmental funding, which are necessary to facilitate and stimulate interdisciplinary cancer research through the scientific programs of the Cancer Center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA016059-28S1
Application #
7688281
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ptak, Krzysztof
Project Start
1978-12-01
Project End
2011-04-30
Budget Start
2008-09-03
Budget End
2009-04-30
Support Year
28
Fiscal Year
2008
Total Cost
$118,723
Indirect Cost
Name
Virginia Commonwealth University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Li, Xiaojiaoyang; Liu, Runping; Huang, Zhiming et al. (2018) Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans. Hepatology 68:599-615
Durant, Stephen T; Zheng, Li; Wang, Yingchun et al. (2018) The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. Sci Adv 4:eaat1719
Damle, S R; Martin, R K; Cockburn, C L et al. (2018) ADAM10 and Notch1 on murine dendritic cells control the development of type 2 immunity and IgE production. Allergy 73:125-136
Wang, Feng; Li, Hongyan; Markovsky, Ela et al. (2018) Pazopanib radio-sensitization of human sarcoma tumors. Oncotarget 9:9311-9324
Stokes, Nancy A; Stanciu, Cristina E; Brocato, Emily R et al. (2018) Simplification of complex DNA profiles using front end cell separation and probabilistic modeling. Forensic Sci Int Genet 36:205-212
Poklepovic, Andrew; Qu, Yuesheng; Dickinson, Molly et al. (2018) Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers. Cardiooncology 4:
Karlin, Jeremy; Allen, Jasmine; Ahmad, Syed F et al. (2018) Orally Bioavailable and Blood-Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice. Mol Cancer Ther 17:1637-1647
Robertson, Chadia L; Mendoza, Rachel G; Jariwala, Nidhi et al. (2018) Astrocyte Elevated Gene-1 Regulates Macrophage Activation in Hepatocellular Carcinogenesis. Cancer Res 78:6436-6446
Kazarian, Elizabeth; Son, HyunYoung; Sapao, Paulene et al. (2018) SPAG17 Is Required for Male Germ Cell Differentiation and Fertility. Int J Mol Sci 19:
Farrell, Nicholas P; Gorle, Anil K; Peterson, Erica J et al. (2018) Metalloglycomics. Met Ions Life Sci 18:

Showing the most recent 10 out of 586 publications